Element Capital Management LLC Sorrento Therapeutics, Inc. Transaction History

Element Capital Management LLC

  • $2.17 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$4.75 - $8.0 $326,054 - $549,144
-68,643 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$4.5 - $9.95 $308,893 - $682,997
68,643 New
68,643 $354,000
Q4 2017

Feb 14, 2018
SELL
$1.75 - $3.8 $21,663 - $47,040
-12,379 Closed
0 $0
Q3 2017

Nov 13, 2017
SELL
$1.63 - $2.0 $337,820 - $414,504
-207,252 Reduced 94.36%
12,379 $21,000
Q2 2017

Aug 14, 2017
BUY
N/A
219,631
219,631 $439,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email